Clinical and molecular characteristics of responders versus non-responders to immune checkpoint inhibitors (ICI) in NSCLC.

被引：1
|
作者：
Shah, Arpeet
Padda, Sukhmani K.
Neal, Joel W.
机构：
[1] Stanford Canc Ctr, Stanford, CA USA
[2] Stanford Canc Inst, Stanford, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 08期
关键词：
D O I：
10.1200/JCO.2019.37.8_suppl.114
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
114
引用
收藏
页数：1
相关论文
共 50 条
  • [21] CHARACTERISTICS OF BONE DENSITY RESPONDERS AND NON-RESPONDERS TO EXERCISE TRAINING.
    Milliken, L. A.
    Flint-Wagner, H. G.
    Figueroa, A.
    Metcalfe, L. L.
    Blew, R. M.
    Sharp, S. C.
    Cussler, E.
    Houtkooper, L. B.
    Going, S. B.
    Lohman, T. G.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2001, 33 (05): : S194 - S194
  • [22] Molecular and metabolic differences of treatment responders versus non-responders in a phase 0 clinical trial of metformin in endometrial cancer.
    Roque, Dario R.
    Schuler, Kevin M.
    Rambally, Brooke S.
    Sampey, Brante
    Everett, Ruth
    Thakker, Dhiren
    Gehrig, Paola A.
    O'Connor, Siobhan
    Makowski, Liza
    Bae-Jump, Victoria Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [23] CLINICAL ATTRIBUTES OF SCHIZOPHRENIC SKIN-CONDUCTANCE RESPONDERS AND NON-RESPONDERS
    GRUZELIER, JH
    PSYCHOLOGICAL MEDICINE, 1976, 6 (02) : 245 - 249
  • [24] Intervention Targeting Reductions In Sedentary Time In Older Cancer Survivors: Characteristics Of Responders Versus Non-responders
    Harding, Elizabeth
    Tarnower, Amy
    Wiggins, Charles
    Williams, Emily
    Schwartz, Matthew
    Medrano, David
    Kinney, Anita Y.
    Blair, Cindy K.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2018, 50 (05): : 714 - 714
  • [25] DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma
    Starzer, Angelika Martina
    Heller, Gerwin
    Tomasich, Erwin
    Melchardt, Thomas
    Feldmann, Katharina
    Hatziioannou, Teresa
    Traint, Stefan
    Minichsdorfer, Christoph
    Schwarz-Nemec, Ursula
    Nackenhorst, Maja
    Muellauer, Leonhard
    Preusser, Matthias
    Berghoff, Anna Sophie
    Fuereder, Thorsten
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (03)
  • [26] Identification of steroid sensitive responders versus non-responders in the treatment of keloid disease
    Sara Ud-Din
    Alison Bowring
    Barbara Derbyshire
    Julie Morris
    Ardeshir Bayat
    Archives of Dermatological Research, 2013, 305 : 423 - 432
  • [27] 'Long Responders' Compared to 'Non-Responders' to a First Line Immune Checkpoint Inhibitor in Incurable Non-Small Cell Lung Cancer
    Rittberg, R.
    Leung, B.
    Shokoohi, A.
    Al Hashami, Z.
    Pender, A.
    Wong, S.
    Wang, Y.
    Ho, C.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S376 - S376
  • [28] Identification of steroid sensitive responders versus non-responders in the treatment of keloid disease
    Ud-Din, Sara
    Bowring, Alison
    Derbyshire, Barbara
    Morris, Julie
    Bayat, Ardeshir
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2013, 305 (05) : 423 - 432
  • [29] USTEKINUMAB RESPONDERS VERSUS NON-RESPONDERS IN REFRACTORY PEDIATRIC INFLAMMATORY BOWEL DISEASE
    Fusillo, Steven J.
    Chang, Vivian
    Stein, Ronen E.
    Maxwell, Elizabeth C.
    Conrad, Maire A.
    Albenberg, Lindsey
    Grossman, Andrew B.
    Mamula, Petar
    Piccoli, David
    Baldassano, Robert N.
    Kelsen, Judith R.
    GASTROENTEROLOGY, 2018, 154 (06) : S82 - S82
  • [30] PLASMA CYTOKINE PROFILES IN IBD PRIMARY NON-RESPONDERS VERSUS RESPONDERS TO INFLIXIMAB
    Buhl, Sine
    Klausen, Pia H.
    Brynskov, Jorn
    Klausen, Tobias Wirenfeldt
    Riis, Lene
    Bendtzen, Klaus
    Steenholdt, Casper
    Rasmussen, Maria
    Nielsen, Ole H.
    Ainsworth, Mark A.
    GASTROENTEROLOGY, 2018, 154 (06) : S393 - S394
12345